Filtration of native and glycated β2-microglobulin by charged and neutral dialysis membranes

Kidney International

Volumn 60, Issue 4, 2001, Pages 1571-1577

  Randoux, Christine ^a   Gillery, Philippe ^a   Georges, Nadine ^a   Lavaud, Sylvie ^a   Chanard, Jacques ^a  

^a REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

AN69 membrane; Chronic uremia; Dialysis related amyloidosis; Hemodialysis, high flux dialysis membrane; Nonenzymatic glycation; Polymethylmethacrylate membrane; Polysulfone membrane

Indexed keywords

BETA 2 MICROGLOBULIN; POLY(METHYL METHACRYLATE); POLYACRYLONITRILE; POLYETHYLENEIMINE; POLYSULFONE;

ADSORPTION; AMYLOIDOSIS; ARTICLE; ARTIFICIAL KIDNEY; COMPARATIVE STUDY; CONTROLLED STUDY; DIALYSIS MEMBRANE; FILTRATION; HUMAN; MEMBRANE PERMEABILITY; MOLECULAR WEIGHT; POROSITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN TRANSPORT; SURFACE CHARGE;

EID: 0034786039     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.00970.x     Document Type: Article

References (42)

1. 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis
2. 2-microglobulin
3. Molecular variants of beta-2 microglobulin in renal insufficiency
4. Advanced oxidation protein products as a novel marker of oxidative stress in uremia
5. Accumulation of carbonyl accelerates the formation of pentoxidine, an advanced glycation end product: Carbonyl stress in uremia
6. 2-microglobulin isoforms in healthy individuals and in amyloid deposits
7. 2-microglobulin in amyloid deposits associated with hemodialysis
8. 2-microglobulin
9. 2-microglobulin is modified with Nε-(carboxymethyl) lysine in dialysis-related amyloidosis
10. 2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis
11. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications
12. Reactive glycosylation end products in diabetic uremia and treatment of renal failure
13. Influence of dialysis modality on plasma and tissue concentration of pentosidine in patients with end-stage renal disease
14. Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: Renal implication in the pathophysiology of pentosidine
15. Carpal tunnel syndrome and type of dialysis membrane
16. Effect of dialysis membrane and patient's age and signs of dialysis-related amyloidosis
17. Radioluscent bone cyst and the type of dialysis membrane in patients undergoing longterm hemodialysis
18. 2-microglobulin turnover in dialyzed patients
19. Evaluation of protein loss during hemofiltration
20. Early and advanced glycosylation end products. Kinetics of formation and clearance in peritoneal dialysis
21. Influence of dialysis modality on plasma and tissue concentration of pentonidine in patients with end-stage renal disease
22. Increased accumulation of the glycoxidation product Nε (carboxymethyl) lysine in human tissue in diabetes and aging
23. Effect of membrane composition and structure on solute removal and biocompatibility
24. A new polymethylmethacylate membrane for hemodialysis
25. Generation and removal of anaphylatoxins during hemofiltrations with five different membranes
26. Anaphylatoxin C3a and C5a adsorption on acrylonitrile membrane of hollow-fiber and plate dialyser: An in-vivo study
27. Lowering plasma levels of complement factor D with AN 69 dialysis membrane
28. High molecular weight kininogen adsorption on hemodialysis membranes: Influence of pH and relationship with contact phase activation of blood plasma: Influence of pre-treatment with poly(ethyleneimine)
29. Activation of the kallikreinkinin system in hemodialysis: Role of membrane electronegativity, blood dilution, and pH
30. Quantification of nonenzymically glycated albumin and total serum protein by affinity chromatography
31. Glucose modification of human serum albumin: A structural study
32. Advanced glycation end product: Characterization of the products from the reaction between D-glucose and serum albumin
33. 2-microglobulin with D-glucose or 3-deoxyglucosome inhibits Aβ2M amyloid fibril extension in vitro
34. Beta 2-microglobulin kinetics in end stage renal failure
35. Beta 2-microglobulin metabolism in uremic patients who are undergoing dialysis
36. Adsorption of low molecular weight protein to hemodialysis membranes: Experimental results and simulation
37. Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy
38. Advanced oxidation protein products as a novel molecular basis of oxidative stress in uremia
39. Influence of hemodialysis membrane type on pentosidine plasma level, a marker of "carbonyl stress"
40. Immunoisolation of hybrid liver support systems by semipermeable membranes